Moderators of exercise effects on self-reported cognitive functioning in cancer survivors: an individual participant data meta-analysis.

Cancer Cognitive functioning Exercise Individual participant data meta-analysis Survivorship

Journal

Journal of cancer survivorship : research and practice
ISSN: 1932-2267
Titre abrégé: J Cancer Surviv
Pays: United States
ID NLM: 101307557

Informations de publication

Date de publication:
09 May 2023
Historique:
received: 28 02 2023
accepted: 25 04 2023
medline: 10 5 2023
pubmed: 10 5 2023
entrez: 9 5 2023
Statut: aheadofprint

Résumé

This individual participant data meta-analysis (IPD-MA) assesses exercise effects on self-reported cognitive functioning (CF) and investigates whether effects differ by patient-, intervention-, and exercise-related characteristics. IPD from 16 exercise RCTs, including 1987 patients across multiple types of non-metastatic cancer, was pooled. A one-stage IPD-MA using linear mixed-effect models was performed to assess exercise effects on self-reported CF (z-score) and to identify whether the effect was moderated by sociodemographic, clinical, intervention- and exercise-related characteristics, or fatigue, depression, anxiety, and self-reported CF levels at start of the intervention (i.e., baseline). Models were adjusted for baseline CF and included a random intercept at study level to account for clustering of patients within studies. A sensitivity analysis was performed in patients who reported cognitive problems at baseline. Minimal significant beneficial exercise effects on self-reported CF (β=-0.09 [-0.16; -0.02]) were observed, with slightly larger effects when the intervention was delivered post-treatment (n=745, β=-0.13 [-0.24; -0.02]), and no significant effect during cancer treatment (n=1,162, β=-0.08 [-0.18; 0.02]). Larger effects were observed in interventions of 12 weeks or shorter (β=-0.14 [-0.25; -0.04]) or 24 weeks or longer (β=-0.18 [-0.32; -0.02]), whereas no effects were observed in interventions of 12-24 weeks (β=0.01 [-0.13; 0.15]). Exercise interventions were most beneficial when provided to patients without anxiety symptoms (β=-0.10 [-0.19; -0.02]) or after completion of treatment in patients with cognitive problems (β=-0.19 [-0.31; -0.06]). No other significant moderators were identified. This cross-cancer IPD meta-analysis observed small beneficial exercise effects on self-reported CF when the intervention was delivered post-treatment, especially in patients who reported cognitive problems at baseline. This study provides some evidence to support the prescription of exercise to improve cognitive functioning. Sufficiently powered trials are warranted to make more definitive recommendations and include these in the exercise guidelines for cancer survivors.

Identifiants

pubmed: 37160571
doi: 10.1007/s11764-023-01392-3
pii: 10.1007/s11764-023-01392-3
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Informations de copyright

© 2023. The Author(s).

Références

Janelsins MC, Kesler SR, Ahles TA, Morrow GR. Prevalence, mechanisms, and management of cancer-related cognitive impairment. Int Rev Psychiatry. 2014;26:102–13.
pubmed: 24716504 pmcid: 4084673 doi: 10.3109/09540261.2013.864260
Al Maqbali M, Al Sinani M, Al Naamani Z, Al Badi K, Tanash MI. Prevalence of fatigue in patients with cancer: a systematic review and meta-analysis. J Pain Symptom Manage. 2021;61:167–189.e14.
pubmed: 32768552 doi: 10.1016/j.jpainsymman.2020.07.037
Niedzwiedz CL, Knifton L, Robb KA, Katikireddi SV, Smith DJ. Depression and anxiety among people living with and beyond cancer: a growing clinical and research priority. BMC Cancer. 2019;19:943.
pubmed: 31604468 pmcid: 6788022 doi: 10.1186/s12885-019-6181-4
Schmidt ME, Goldschmidt S, Hermann S, Steindorf K. Late effects, long-term problems and unmet needs of cancer survivors. Int J Cancer. 2022;151:1280–90.
pubmed: 35657637 doi: 10.1002/ijc.34152
Oerlemans S, Schagen SB, van den Hurk CJ, Husson O, Schoormans D, van de Poll-Franse LV. Self-perceived cognitive functioning and quality of life among cancer survivors: results from the PROFILES registry. J Cancer Surviv. 2022;16:303–13.
pubmed: 33728574 doi: 10.1007/s11764-021-01023-9
Bray VJ, Dhillon HM, Vardy JL. Systematic review of self-reported cognitive function in cancer patients following chemotherapy treatment. J Cancer Surviv. 2018;12:537–59.
pubmed: 29728959 doi: 10.1007/s11764-018-0692-x
Schmidt JE, Beckjord E, Bovbjerg DH, Low CA, Posluszny DM, Lowery AE, et al. Prevalence of perceived cognitive dysfunction in survivors of a wide range of cancers: results from the 2010 LIVESTRONG survey. J Cancer Surviv. 2016;10:302–11.
pubmed: 26238504 doi: 10.1007/s11764-015-0476-5
Ahles TA, Root JC. Cognitive effects of cancer and cancer treatments. Annu Rev Clin Psychol. 2018;14:425–51.
pubmed: 29345974 pmcid: 9118140 doi: 10.1146/annurev-clinpsy-050817-084903
Boykoff N, Moieni M, Subramanian SK. Confronting chemobrain: an in-depth look at survivors’ reports of impact on work, social networks, and health care response. J Cancer Surviv. 2009;3:223.
pubmed: 19760150 pmcid: 2775113 doi: 10.1007/s11764-009-0098-x
Schmidt ME, Scherer S, Wiskemann J, Steindorf K. Return to work after breast cancer: the role of treatment-related side effects and potential impact on quality of life. Eur J Cancer Care. 2019;28:e13051.
doi: 10.1111/ecc.13051
Lycke M, Lefebvre T, Pottel L, Pottel H, Ketelaars L, Stellamans K, et al. Subjective, but not objective, cognitive complaints impact long-term quality of life in cancer patients. J Psychosoc Oncol. 2019;37:427–40.
pubmed: 30798774 doi: 10.1080/07347332.2018.1504154
McDonald BC. Structural neuroimaging findings related to adult Non-CNS cancer and treatment: review, integration, and implications for treatment of cognitive dysfunction. Neurotherapeutics. 2021;18:792–810.
pubmed: 34402034 pmcid: 8423886 doi: 10.1007/s13311-021-01096-5
Campbell KL, Winters-Stone KM, Wiskemann J, May AM, Schwartz AL, Courneya KS, et al. Exercise guidelines for cancer survivors: consensus statement from International Multidisciplinary Roundtable. Med Sci Sports Exerc. 2019;51:2375–90.
pubmed: 31626055 pmcid: 8576825 doi: 10.1249/MSS.0000000000002116
Buffart LM, Kalter J, Sweegers MG, Courneya KS, Newton RU, Aaronson NK, et al. Effects and moderators of exercise on quality of life and physical function in patients with cancer: an individual patient data meta-analysis of 34 RCTs. Cancer Treat Rev. 2017;52:91–104.
pubmed: 28006694 doi: 10.1016/j.ctrv.2016.11.010
Zimmer P, Baumann FT, Oberste M, Wright P, Garthe A, Schenk A, et al. Effects of exercise interventions and physical activity behavior on cancer related cognitive impairments: a systematic review. Biomed Res Int. 2016;2016:1820954.
pubmed: 27144158 pmcid: 4842032 doi: 10.1155/2016/1820954
Liu PZ, Nusslock R. Exercise-mediated neurogenesis in the hippocampus via BDNF. Front Neurosci. 2018;12:52.
pubmed: 29467613 pmcid: 5808288 doi: 10.3389/fnins.2018.00052
Falck RS, Davis JC, Best JR, Crockett RA, Liu-Ambrose T. Impact of exercise training on physical and cognitive function among older adults: a systematic review and meta-analysis. Neurobiol Aging. 2019;79:119–30.
pubmed: 31051329 doi: 10.1016/j.neurobiolaging.2019.03.007
Biazus-Sehn LF, Schuch FB, Firth J, de Stigger FS. Effects of physical exercise on cognitive function of older adults with mild cognitive impairment: a systematic review and meta-analysis. Arch Gerontol Geriatr. 2020;89:104048.
pubmed: 32460123 doi: 10.1016/j.archger.2020.104048
Campbell KL, Winters-Stone KM, Wiskemann J, May AM, Schwartz AL, Courneya KS, et al. Exercise Guidelines for Cancer Survivors: consensus statement from International Multidisciplinary Roundtable. Med Sci Sports Exerc. 2019;51:2375–90.
pubmed: 31626055 pmcid: 8576825 doi: 10.1249/MSS.0000000000002116
Campbell KL, Zadravec K, Bland KA, Chesley E, Wolf F, Janelsins MC. The effect of exercise on cancer-related cognitive impairment and applications for physical therapy: systematic review of randomized controlled trials. Phys Ther. 2020;100:523–42.
pubmed: 32065236 pmcid: 8559683 doi: 10.1093/ptj/pzz090
Witlox L, Schagen SB, de Ruiter MB, Geerlings MI, Peeters PHM, Koevoets EW, et al. Effect of physical exercise on cognitive function and brain measures after chemotherapy in patients with breast cancer (PAM study): protocol of a randomised controlled trial. BMJ Open. 2019;9:e028117.
pubmed: 31227537 pmcid: 6597001 doi: 10.1136/bmjopen-2018-028117
Koevoets EW, Schagen SB, de Ruiter MB, Geerlings MI, Witlox L, van der Wall E, et al. Effect of physical exercise on cognitive function after chemotherapy in patients with breast cancer: a randomized controlled trial (PAM study). Breast Cancer Res. 2022;24:36.
pubmed: 35619188 pmcid: 9135390 doi: 10.1186/s13058-022-01530-2
Koevoets EW, Schagen SB, de Ruiter MB, Geerlings MI, Witlox L, van der Wall E, et al. Effect of physical exercise on cognitive function after chemotherapy in patients with breast cancer: a randomized controlled trial (PAM study). Breast Cancer Res. 2022;24:36. https://doi.org/10.1186/s13058-022-01530-2 .
doi: 10.1186/s13058-022-01530-2 pubmed: 35619188 pmcid: 9135390
Hartman SJ, Nelson SH, Myers E, Natarajan L, Sears DD, Palmer BW, et al. Randomized controlled trial of increasing physical activity on objectively measured and self-reported cognitive functioning among breast cancer survivors: the memory & motion study. Cancer. 2018;124:192–202. https://acsjournals.onlinelibrary.wiley.com/doi/abs/10.1002/cncr.30987 .
pubmed: 28926676 doi: 10.1002/cncr.30987
Debray TPA, Moons KGM, van Valkenhoef G, Efthimiou O, Hummel N, Groenwold RHH, et al. Get real in individual participant data (IPD) meta-analysis: a review of the methodology. Res Synth Methods. 2015;6:293–309.
pubmed: 26287812 pmcid: 5042043 doi: 10.1002/jrsm.1160
Riley RD, Lambert PC, Abo-Zaid G. Meta-analysis of individual participant data: rationale, conduct, and reporting. BMJ. 2010;340
Buffart LM, Kalter J, Chinapaw MJM, Heymans MW, Aaronson NK, Courneya KS, et al. Predicting OptimaL cAncer RehabIlitation and Supportive care (POLARIS): rationale and design for meta-analyses of individual patient data of randomized controlled trials that evaluate the effect of physical activity and psychosocial interventions on healt. Syst Rev. 2013;2:75.
pubmed: 24034173 pmcid: 3848838 doi: 10.1186/2046-4053-2-75
Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 2021;372:n71.
pubmed: 33782057 pmcid: 8005924 doi: 10.1136/bmj.n71
Aaronson N, Ahmedzai S, Bergman B, Bullinger M, Cull A, Duez N, et al. The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology. J Natl Cancer Inst. 1993;85:365–76.
pubmed: 8433390 doi: 10.1093/jnci/85.5.365
Cormie P, Galvão DA, Spry N, Joseph D, Chee R, Taaffe DR, et al. Can supervised exercise prevent treatment toxicity in patients with prostate cancer initiating androgen-deprivation therapy: a randomised controlled trial. BJU Int. 2015;115:256–66.
pubmed: 24467669 doi: 10.1111/bju.12646
Galvão DA, Taaffe DR, Spry N, Joseph D, Newton RU. Combined resistance and aerobic exercise program reverses muscle loss in men undergoing androgen suppression therapy for prostate cancer without bone metastases: a randomized controlled trial. J Clin Oncol. 2010;28:340–7.
pubmed: 19949016 doi: 10.1200/JCO.2009.23.2488
Galvão DA, Spry N, Denham J, Taaffe DR, Cormie P, Joseph D, et al. A multicentre year-long randomised controlled trial of exercise training targeting physical functioning in men with prostate cancer previously treated with androgen suppression and radiation from TROG 03.04 RADAR. Eur Urol. 2014;65:856–64.
pubmed: 24113319 doi: 10.1016/j.eururo.2013.09.041
Mehnert A, Veers S, Howaldt D, Braumann K-M, Koch U, Schulz K-H. Effects of a physical exercise rehabilitation group program on anxiety, depression, body image, and health-related quality of life among breast cancer patients. Oncol Res Treat. 2011;34:248–53.
Thorsen L, Skovlund E, Strømme SB, Hornslien K, Dahl AA, Fosså SD. Effectiveness of physical activity on cardiorespiratory fitness and health-related quality of life in young and middle-aged cancer patients shortly after chemotherapy. J Clin Oncol. 2005;23:2378–88.
pubmed: 15800330 doi: 10.1200/JCO.2005.04.106
Winters-Stone KM, Dobek JC, Bennett JA, Dieckmann NF, Maddalozzo GF, Ryan CW, et al. Resistance training reduces disability in prostate cancer survivors on androgen deprivation therapy: evidence from a randomized controlled trial. Arch Phys Med Rehabil. 2015;96:7–14.
pubmed: 25194450 doi: 10.1016/j.apmr.2014.08.010
Taaffe DR, Newton RU, Spry N, Joseph D, Chambers SK, Gardiner RA, et al. Effects of different exercise modalities on fatigue in prostate cancer patients undergoing androgen deprivation therapy: a year-long randomised controlled trial. Eur Urol. 2017;72:293–9.
pubmed: 28249801 doi: 10.1016/j.eururo.2017.02.019
Smets EMA, Garssen B, Bonke B, De Haes JCJM. The Multidimensional Fatigue Inventory (MFI) psychometric qualities of an instrument to assess fatigue. J Psychosom Res. 1995;39:315–25.
pubmed: 7636775 doi: 10.1016/0022-3999(94)00125-O
Kampshoff CS, Chinapaw MJM, Brug J, Twisk JWR, Schep G, Nijziel MR, et al. Randomized controlled trial of the effects of high intensity and low-to-moderate intensity exercise on physical fitness and fatigue in cancer survivors: results of the Resistance and Endurance exercise After ChemoTherapy (REACT) study. BMC Med. 2015;13:275.
pubmed: 26515383 pmcid: 4625937 doi: 10.1186/s12916-015-0513-2
Korstjens I, May AM, van Weert E, Mesters I, Tan F, Ros WJG, et al. Quality of life after self-management cancer rehabilitation: a randomized controlled trial comparing physical and cognitive-behavioral training versus physical training. Psychosom Med. 2008;70:422–9.
pubmed: 18480190 doi: 10.1097/PSY.0b013e31816e038f
Travier N, Velthuis MJ, Steins Bisschop CN, van den Buijs B, Monninkhof EM, Backx F, et al. Effects of an 18-week exercise programme started early during breast cancer treatment: a randomised controlled trial. BMC Med. BMC Med. 2015;13:121.
pubmed: 26050790 pmcid: 4461906 doi: 10.1186/s12916-015-0362-z
van Vulpen JK, Velthuis MJ, Steins Bisschop CN, Travier N, van den Buijs BJW, Backx FJG, et al. Effects of an exercise program in colon cancer patients undergoing chemotherapy. Med Sci Sports Exerc. 2016;48:767–75.
pubmed: 26694846 doi: 10.1249/MSS.0000000000000855
Van Waart H, Stuiver MM, Van Harten WH, Geleijn E, Kieffer JM, Buffart LM, et al. Effect of low-intensity physical activity and moderate- to high-intensity physical exercise during adjuvant chemotherapy on physical fitness, fatigue, and chemotherapy completion rates: Results of the PACES randomized clinical trial. J Clin Oncol. 2015;33:1918–27.
pubmed: 25918291 doi: 10.1200/JCO.2014.59.1081
Wiskemann J, Dreger P, Schwerdtfeger R, Bondong A, Huber G, Kleindienst N, et al. Effects of a partly self-administered exercise program before, during, and after allogeneic stem cell transplantation. Blood. 2011;117:2604–13.
pubmed: 21190995 doi: 10.1182/blood-2010-09-306308
Persoon S, ChinAPaw MJM, Buffart LM, Liu RDK, Wijermans P, Koene HR, et al. Randomized controlled trial on the effects of a supervised high intensity exercise program in patients with a hematologic malignancy treated with autologous stem cell transplantation: Results from the EXIST study. PloS One. 2017;12:e0181313.
pubmed: 28727771 pmcid: 5519072 doi: 10.1371/journal.pone.0181313
Vercoulen JH, Swanink CM, Fennis JF, Galama JM, van der Meer JW, Bleijenberg G. Dimensional assessment of chronic fatigue syndrome. J Psychosom Res. 1994;38:383–92.
pubmed: 7965927 doi: 10.1016/0022-3999(94)90099-X
Goedendorp MM, Peters MEWJ, Gielissen MFM, Witjes JA, Leer JW, Verhagen CAHHVM, et al. Is increasing physical activity necessary to diminish fatigue during cancer treatment? comparing cognitive behavior therapy and a brief nursing intervention with usual care in a multicenter randomized controlled trial. Oncologist. 2010;15:1122–32.
pubmed: 20930100 pmcid: 3227893 doi: 10.1634/theoncologist.2010-0092
Glaus A, Müller S. Measuring fatigue of cancer patients in the German-speaking region: development of the Fatigue Assessment Questionnaire. Pflege. 2001;14:161–70.
pubmed: 12385268 doi: 10.1024/1012-5302.14.3.161
Schmidt ME, Wiskemann J, Armbrust P, Schneeweiss A, Ulrich CM, Steindorf K. Effects of resistance exercise on fatigue and quality of life in breast cancer patients undergoing adjuvant chemotherapy: a randomized controlled trial. Int J Cancer. 2015;137:471–80.
pubmed: 25484317 doi: 10.1002/ijc.29383
Steindorf K, Schmidt ME, Klassen O, Ulrich CM, Oelmann J, Habermann N, et al. Randomized, controlled trial of resistance training in breast cancer patients receiving adjuvant radiotherapy: results on cancer-related fatigue and quality of life. Ann Oncol. 2014;25:2237–43.
pubmed: 25096607 doi: 10.1093/annonc/mdu374
Cohen J. Statistical power analysis for the behavioral sciences. 2nd ed. Hillsdale, NJ: Lawrence Earlbaum; 1988.
Van Waart H, Stuiver MM, Van Harten WH, Geleijn E, Kieffer JM, Buffart LM, et al. Effect of low-intensity physical activity and moderate- to high-intensity physical exercise during adjuvant chemotherapy on physical fitness, fatigue, and chemotherapy completion rates: results of the PACES randomized clinical trial. J Clin Oncol. 2015;33:1918–27.
pubmed: 25918291 doi: 10.1200/JCO.2014.59.1081
Annunziata MA, Muzzatti B, Bidoli E, Flaiban C, Bomben F, Piccinin M, et al. Hospital Anxiety and Depression Scale (HADS) accuracy in cancer patients. Support Care Cancer. 2020;28:3921–6.
pubmed: 31858249 doi: 10.1007/s00520-019-05244-8
Feenstra HEM, Murre JMJ, Vermeulen IE, Kieffer JM, Schagen SB. Reliability and validity of a self-administered tool for online neuropsychological testing: the Amsterdam Cognition Scan. J Clin Exp Neuropsychol. 2018;40:253–73. https://doi.org/10.1080/13803395.2017.1339017 .
doi: 10.1080/13803395.2017.1339017 pubmed: 28671504
Hartman SJ, Nelson SH, Myers E, Natarajan L, Sears DD, Palmer BW, et al. Randomized controlled trial of increasing physical activity on objectively measured and self-reported cognitive functioning among breast cancer survivors: the memory & motion study. Cancer. 2018;124:192–202.
pubmed: 28926676 doi: 10.1002/cncr.30987
Janelsins MC, Heckler CE, Peppone LJ, Kamen C, Mustian KM, Mohile SG, et al. Cognitive complaints in survivors of breast cancer after chemotherapy compared with age-matched controls: an analysis from a nationwide, multicenter, prospective longitudinal study. J Clin Oncol. 2016;35:506–14.
pubmed: 28029304 pmcid: 5455314 doi: 10.1200/JCO.2016.68.5826
Kampshoff CS, van Mechelen W, Schep G, Nijziel MR, Witlox L, Bosman L, et al. Participation in and adherence to physical exercise after completion of primary cancer treatment. Int J Behav Nutr Phys Act. 2016;13:100.
pubmed: 27612561 pmcid: 5016937 doi: 10.1186/s12966-016-0425-3
Costa DSJ, Fardell JE. Why are objective and perceived cognitive function weakly correlated in patients with cancer? J Clin Oncol. 2019;37:1154–8. https://doi.org/10.1200/JCO.18.02363 .
doi: 10.1200/JCO.18.02363 pubmed: 30920881
Campbell KL, Kam JWY, Neil-Sztramko SE, Liu Ambrose T, Handy TC, Lim HJ, et al. Effect of aerobic exercise on cancer-associated cognitive impairment: a proof-of-concept RCT. Psychooncology. 2018;27:53–60.
pubmed: 28075038 doi: 10.1002/pon.4370
Gehring K, Stuiver MM, Visser E, Kloek C, van den Bent M, Hanse M, et al. A pilot randomized controlled trial of exercise to improve cognitive performance in patients with stable glioma: a proof of concept. Neuro Oncol. 2020;22:103–15.
pubmed: 31755917 doi: 10.1093/neuonc/noz178

Auteurs

Anouk E Hiensch (AE)

Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands.

Julia Beckhaus (J)

Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands.

Lenja Witlox (L)

Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands.

Evelyn M Monninkhof (EM)

Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands.

Sanne B Schagen (SB)

Division of Psychosocial Research and Epidemiology, Netherlands Cancer Institute, Amsterdam, The Netherlands.

Jonna K van Vulpen (JK)

Department of Radiation Oncology, University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands.

Maike G Sweegers (MG)

Division of Psychosocial Research and Epidemiology & Center for Quality of Life, Netherlands Cancer Institute, Amsterdam, The Netherlands.

Robert U Newton (RU)

Exercise Medicine Research Institute, Edith Cowan University, Perth, WA, Australia.

Neil K Aaronson (NK)

Division of Psychosocial Research and Epidemiology, Netherlands Cancer Institute, Amsterdam, The Netherlands.

Daniel A Galvão (DA)

Exercise Medicine Research Institute, Edith Cowan University, Perth, WA, Australia.

Karen Steindorf (K)

Division of Physical Activity, Prevention and Cancer, German Cancer Research Center (DKFZ) and National Center for Tumor Diseases (NCT) Heidelberg, Heidelberg, Germany.

Martijn M Stuiver (MM)

Division of Psychosocial Research and Epidemiology & Center for Quality of Life, Netherlands Cancer Institute, Amsterdam, The Netherlands.

Ilse Mesters (I)

Department of Epidemiology, Maastricht University, Maastricht, The Netherlands.

Hans Knoop (H)

Department of Medical Psychology, Amsterdam UMC location University of Amsterdam, Amsterdam, The Netherlands.

Martine M Goedendorp (MM)

Department of Health Psychology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands.
Department of Health Sciences, Faculty of Science, Vrije Universiteit Amsterdam, Amsterdam Public Health Research Institute, Amsterdam, The Netherlands.

Martin Bohus (M)

Institute of Psychiatric and Psychosomatic Psychotherapy, Central Institute of Mental Health, Mannheim, Heidelberg University, Heidelberg, Germany.
Faculty of Health, University of Antwerp, Antwerp, Belgium.

Lene Thorsen (L)

National Advisory Unit on Late Effects after Cancer, Department of Oncology, Oslo University Hospital, Oslo, Norway.
Department of Clinical Service, Division of Cancer Medicine, Oslo University Hospital, Oslo, Norway.

Karl-Heinz Schulz (KH)

Athleticum - Competence Center for Sports- and Exercise Medicine and Institute for Medical Psychology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.

Martina E Schmidt (ME)

Division of Physical Activity, Prevention and Cancer, German Cancer Research Center (DKFZ) and National Center for Tumor Diseases (NCT) Heidelberg, Heidelberg, Germany.

Cornelia M Ulrich (CM)

Huntsman Cancer Institute and Department of Population Health Sciences, University of Utah, Salt Lake City, USA.

Gabe S Sonke (GS)

Netherlands Cancer Institute, Amsterdam, The Netherlands.

Wim H van Harten (WH)

Division of Psychosocial Research and Epidemiology, Netherlands Cancer Institute, Amsterdam, The Netherlands.
Department of Health Technology and Services Research, University of Twente, Enschede, The Netherlands.

Kerri M Winters-Stone (KM)

Division of Oncological Sciences, Knight Cancer Institute, Oregon Health & Science University, Portland, OR, USA.

Miranda J Velthuis (MJ)

Netherlands Comprehensive Cancer Organisation (IKNL), Utrecht, The Netherlands.

Dennis R Taaffe (DR)

Exercise Medicine Research Institute, Edith Cowan University, Perth, WA, Australia.

Willem van Mechelen (W)

Department of Public and Occupational Health, Amsterdam Public Health Research Institute, Amsterdam UMC, location: Vrije Universiteit, Amsterdam, The Netherlands.
School of Human Movement and Nutrition Sciences, Faculty of Health and Behavioural Sciences, University of Queensland, Brisbane, Australia.
Division of Exercise Science and Sports Medicine (ESSM), Department of Human Biology, Faculty of Health Sciences, University of Cape Town, Cape Town, South Africa.
School of Public Health, Physiotherapy and Population Sciences, University College Dublin, Dublin, Ireland.

Marie José Kersten (MJ)

Department of Hematology, Amsterdam University Medical Centers, Location University of Amsterdam, Cancer Center Amsterdam, Amsterdam, The Netherlands.

Frans Nollet (F)

Department of Rehabilitation Medicine, Amsterdam UMC location University of Amsterdam, Amsterdam, The Netherlands.
Amsterdam Movement Sciences, Rehabilitation & Development, Amsterdam, The Netherlands.

Joachim Wiskemann (J)

Working Group Exercise Oncology, Division of Medical Oncology, University Clinic Heidelberg and National Center for Tumor Diseases (NCT), Heidelberg, Germany.

Laurien M Buffart (LM)

Exercise Medicine Research Institute, Edith Cowan University, Perth, WA, Australia. Laurien.Buffart@radboudumc.nl.
Department of Physiology, Radboudumc, Nijmegen, The Netherlands. Laurien.Buffart@radboudumc.nl.

Anne M May (AM)

Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands.

Classifications MeSH